- FDA issues first EUA for SARS-CoV2 IgM/IgG rapid test.
- This test is for laboratories that possess a non-waived CLIA certificate.
- There is currently no fingerstick claim for the use of this test.
Are any HFAP Standards affected? No. This is provided for information only.
Read associated documents below.